Primary Article

Stability of Midazolam Prepared for Oral Administration

Authors: DAVID F. GREGORY, BS, RPh, JAMES A. KOESTNER, PharmD, JOSEPH D. TOBIAS, MD

Abstract

Midazolam is used frequently as an oral premedication in children. To make it more palatable, it is often mixed in various syrups and solutions. No previous studies have documented the stability of midazolam when mixed in these solutions. Using high-pressure liquid chromatography, we assayed midazolam concentrations over time when mixed at two different concentrations (2.5 mg/mL and 3.0 mg/mL) in a sucrosebased syrup (Simple Syrup, NF). Each assay was done in triplicate on three different days (days 1, 14, and 38). Solution A concentrations (2.5 mg/mL) were 2.28 mg/mL on day 1, 2.26 mg/mL on day 14, and 1.82 mg/mL on day 38. Solution B concentrations (3.0 mg/mL) were 2.82 mg/mL on day 1, 2.91 mg/mL on day 14, and 2.24 mg/mL on day 38. Our results confirm the stability of midazolam for up to 14 days when mixed for oral administration.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References